
|Videos|October 7, 2015
Challenges in Clinical Support for Specialty Therapies
Author(s)Davy James, Managing Editor
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.
Advertisement
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
More Dose Adjustments, Similar Outcomes: Ribociclib vs Palbociclib in Practice
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5




































































































































































































